https://www.selleckchem.com/pr....oducts/Gefitinib.htm
0001). Children with ALL who had high plasma levels of YKL-40 (≥36.34 ng/ml) had shorter survival compared with those with low levels ( less then 36.34 ng/ml; P less then 0.05). The findings of the present study revealed that the YKL-40 plasma level, age/initial leukocyte count and central nervous system invasion were associated with the prognosis of children with ALL [odds ratio (OR)=6.06, 95% confidence interval (CI) 1.1-31.6, P=0.03; OR=8.53, 95% CI 1.2-58.2, P=0.03; and OR=6.45, 95% CI 1.01-41.2, P=0.04, respectively]. Therefore,
Like
Comment
Share
